Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Receivables (2020 - 2021)

Historic Receivables for Candel Therapeutics (CADL) over the last 2 years, with Q4 2021 value amounting to $1.1 million.

  • Candel Therapeutics' Receivables rose 7243.59% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 7243.59%. This contributed to the annual value of $1.1 million for FY2021, which is 7243.59% up from last year.
  • According to the latest figures from Q4 2021, Candel Therapeutics' Receivables is $1.1 million, which was up 7243.59% from $191000.0 recorded in Q1 2021.
  • Candel Therapeutics' 5-year Receivables high stood at $1.1 million for Q4 2021, and its period low was $191000.0 during Q1 2021.